Imaging tau pathology in Parkinsonisms
Abstract The recent development of positron emission tomography radiotracers targeting pathological tau in vivo has led to numerous human trials. While investigations have primarily focused on the most common tauopathy, Alzheimer’s disease, it is imperative that testing also be performed in parkinso...
Main Authors: | Sarah Coakeley, Antonio P. Strafella |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-06-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-017-0023-3 |
Similar Items
-
Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
by: Sanskriti Sasikumar, et al.
Published: (2020-01-01) -
Association of MAPT (tau) haplotype with the pathology of Parkinson's disease
by: Parkkinen, L, et al.
Published: (2013) -
Disrupted nodal and hub organization account for brain network abnormalities in Parkinson’s disease
by: Yuko Koshimori, et al.
Published: (2016-11-01) -
Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
by: Chul Hyoung Lyoo, et al.
Published: (2018-01-01) -
The significance of α-Synuclein, Amyloid-β and Tau pathologies in Parkinson's disease progression and related dementia
by: Compta, Y, et al.
Published: (2013)